Greenwich LifeSciences secures UK approval to expand Phase III breast cancer trial
Arrowhead reports positive Phase 3 results for plozasiran in severe hypertriglyceridaemia
Ipsen completes Memo Therapeutics acquisition to strengthen rare disease pipeline
Hugel Aesthetics expands US presence
WuXi AppTec named to FTSE4Good Index Series for fourth consecutive year
European Commission expands Crysvita approval to infants with XLH
Akagera Medicines reports positive first-in-human data for AKG-100
Argo Biopharma doses first participant in Phase I trial of factor XI targeting siRNA therapy
Almirall advances Ebglyss paediatric regulatory filing in Europe
Sareum completes dosing in Phase 2-enabling toxicology programme for SDC-1801
GSK seeks European approval for single-dose Bexsero booster in older children and adults
Evaxion to present three-year cancer vaccine data at ESMO Congress 2026
Aqemia and Sanofi expand drug discovery collaboration with new research target